comparemela.com

Latest Breaking News On - Calithera biosciences - Page 1 : comparemela.com

Calithera Biosciences (NASDAQ:CALA) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a report published on Friday. The firm issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance Shares of NASDAQ:CALA opened at $0.02 on Friday. Calithera Biosciences has a 12-month low of $0.02 and a 12-month high of $0.50. […]

South-san-francisco
California
United-states
Calithera-biosciences
Nasdaq
Calithera-biosciences-company-profile
Calithera-biosciences-inc
Free-report
Get-free-report
Calithera-biosciences-daily

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.

United-states
Japan
Taiwan
Junshi
Anhui
China
Helsinki
Eteläuomen-läi
Finland
Germany
Qilu
Gansu

Calithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report released on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance Shares of NASDAQ:CALA opened at $0.02 on Friday. The firm has a 50 day moving average of $0.02 and a 200 […]

South-san-francisco
California
United-states
Calithera-biosciences
Calithera-biosciences-inc
Nasdaq
Free-report
Get-free-report
Calithera-biosciences-daily

Analysts' New Coverage for May 24th (AEZS, AIRG, AWX, AZUL, BCLI, BLPH, BWMN, BZ, CALA, CAMP)

Analysts' New Coverage for May 24th (AEZS, AIRG, AWX, AZUL, BCLI, BLPH, BWMN, BZ, CALA, CAMP)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Sanfordc-bernstein
Redburn-atlantic
Innsuites-hospitality-trust
Citigroup-inc
News-ratings-for-aeterna-zentaris-inc-daily
Marin-software
Jaguar-health
Cb-financial-services
International-tower-hill-mines
Bowman-consulting-group

Calithera Biosciences (NASDAQ:CALA) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report released on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Stock Performance Calithera Biosciences stock opened at $0.02 on Thursday. The stock has a 50-day moving average of $0.02 and a two-hundred […]

South-san-francisco
California
United-states
Calithera-biosciences
Calithera-biosciences-inc
Free-report
Get-free-report
Calithera-biosciences-daily

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.